CapsoVision CV
NASDAQ CV
$6.32 -0.14 (-2.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2026)

Updated

CapsoVision (CV) reported Liabilities and Shareholders Equity of $18.57 million for Q2 2026, up 94.5% from $9.55 million a year earlier.

Analysis

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, CapsoVision posted Liabilities and Shareholders Equity of $18.16 million, up 8.1% from FY2024.

  • By year, Liabilities and Shareholders Equity came in at $16.8 million in FY2024.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $9.55 million in Q2 2025 and a high of $25.66 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 CapsoVision 323.21 Mn 323.21 Mn 1.87 Mn 18.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.57 Mn
Dec 31, 2025 18.16 Mn
Sep 30, 2025 25.66 Mn
Jun 30, 2025 9.55 Mn
Dec 31, 2024 16.80 Mn
API Access

CapsoVision Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CV&period=max&api_key=YOUR_API_KEY